Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2429 (LINC02429)

Target
LINC02429
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA) (a broader family)
01

Overview

Long intergenic non-protein coding RNA 2429 (LINC02429) is a human gene that produces a long intergenic non-coding RNA (lincRNA), a subclass of long non-coding RNAs (lncRNAs) defined as autonomously transcribed non-coding RNAs longer than 200 nucleotides that do not overlap protein-coding genes[1][3][5]. LincRNAs, including LINC02429, are typically involved in the regulation of gene expression at transcriptional and epigenetic levels, often modulating chromatin structure, recruiting regulatory proteins, or acting as enhancer RNAs[5]. While the biological functions of many lincRNAs remain under-characterized, they are generally viewed as fine-tuners of gene expression, and some have been shown to influence processes such as chromatin remodeling, transcription regulation, and possibly cell-type-specific regulatory activity[5]. As of now, there is no evidence that LINC02429 itself is a therapeutic target or that it interacts with any drugs, nor is there direct evidence linking it to specific diseases[1][3].

Other names
LINC02429long intergenic non-protein coding RNA 2429
02

Biological functions

Chromatin remodelingRegulation of transcriptionPotential RNA stabilizationEnhancer-like activityRegulation of neighboring gene expression
03

Disease associations

Other (no specific direct disease association identified for LINC02429 itself as of current data; general lincRNAs are often implicated in cancers and other diseases but specific evidence for LINC02429 is lacking)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2429 (LINC02429).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2429 (LINC02429).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call